Fosamax linked to Strokes

A study published this week in the Archives of Internal Medicine reveals a higher risk of atrial fibrillation by those who take alendronate, or its name brand counterpart, Fosomax.

Researchers compared more than 700 women with atrial fibrillation had who had taken alendronate with those who had not and found that women who had ever taken the popular drug for osteoporosis are at 86 per cent higher risk of atrial fibrillation, a condition where the top two chambers of the heart, quiver and beat rapidly instead of rhythmically.

The most serious complication of atrial fibrillation can be stroke, caused by blood accumulating in the atria, forming a clot; a piece of which can break off and travel to the brain. Other symptoms include rapid heart rate, palpitations in the chest and shortness of breath. In Canada alone, more than three million prescriptions for alendronate were dispensed from retail drug stores in one year.

Fosamax Stroke in the News

APR-30-08: Another research study has found a possible connection between Fosamax and atrial fibrillation. [MSNBC: FOSAMAX]

APR-29-08: Researchers find that women who take Fosamax are 86% more likely to suffer a stroke. [VANCOUVER SUN: FOSAMAX STROKE]

Fosamax Stroke Legal Help

If you or a loved one have taken Fosamax and subsequently suffered a stroke, please click the link below to send your complaint to a lawyer to evaluate your claim at no cost or obligation.